Met Life Investment Management, LLC Castle Biosciences Inc Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 14,372 shares of CSTL stock, worth $395,661. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,372

Previous 14,372 -0.0%

Holding current value

$395,661

Previous $312,000 31.09%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$18.84 - $24.94 $37,736 - $49,954	2,003 Added 16.19%	14,372 $312,000
Q1 2024 May 14, 2024	BUY	$18.06 - $25.3 $223,384 - $312,935	12,369 New	12,369 $273,000
Q2 2023 Apr 29, 2024	BUY	$11.66 - $26.0 $144,222 - $321,594	12,369 New	12,369 $169,000
Q1 2023 May 09, 2024	BUY	$19.47 - $28.49 $240,824 - $352,392	12,369 New	12,369 $281 Million
Q1 2022 May 10, 2024	BUY	$33.17 - $46.98 $410,279 - $581,095	12,369 New	12,369 $554,000
Q1 2022 Mar 22, 2023	BUY	$33.17 - $46.98 $151,421 - $214,463	4,565 Added 58.5%	12,369 $554,000
Q1 2022 May 12, 2022	BUY	$33.17 - $46.98 $151,421 - $214,463	4,565 Added 58.5%	12,369 $555,000
Q4 2021 Jun 21, 2023	SELL	$39.06 - $67.58 $178,308 - $308,502	-4,565 Reduced 36.91%	7,804 $334,000
Q3 2021 Jun 21, 2023	SELL	$60.13 - $77.6 $274,493 - $354,244	-4,565 Reduced 36.91%	7,804 $518,000
Q2 2021 May 17, 2024	BUY	$50.07 - $76.78 $101,141 - $155,095	2,020 Added 34.92%	7,804 $572,000
Q2 2021 Jun 21, 2023	SELL	$50.07 - $76.78 $228,569 - $350,500	-4,565 Reduced 36.91%	7,804 $572,000
Q2 2021 Mar 22, 2023	BUY	$50.07 - $76.78 $101,141 - $155,095	2,020 Added 34.92%	7,804 $572,000
Q2 2021 Aug 16, 2021	BUY	$50.07 - $76.78 $101,141 - $155,095	2,020 Added 34.92%	7,804 $572,000
Q1 2021 May 17, 2024	SELL	$58.92 - $97.33 $387,988 - $640,918	-6,585 Reduced 53.24%	5,784 $395,000
Q1 2021 Jun 26, 2023	SELL	$58.92 - $97.33 $387,988 - $640,918	-6,585 Reduced 53.24%	5,784 $396 Million
Q1 2021 Mar 22, 2023	BUY	$58.92 - $97.33 $69,289 - $114,460	1,176 Added 25.52%	5,784 $395,000
Q1 2021 May 14, 2021	BUY	$58.92 - $97.33 $69,289 - $114,460	1,176 Added 25.52%	5,784 $396,000
Q4 2020 Jun 22, 2023	SELL	$43.6 - $73.05 $338,379 - $566,941	-7,761 Reduced 62.75%	4,608 $309,000
Q3 2020 Jun 26, 2023	SELL	$38.47 - $52.03 $298,565 - $403,804	-7,761 Reduced 62.75%	4,608 $237,000
Q2 2020 May 24, 2024	SELL	$27.28 - $43.01 $211,720 - $333,800	-7,761 Reduced 62.75%	4,608 $174 Million
Q2 2020 Jun 26, 2023	SELL	$27.28 - $43.01 $211,720 - $333,800	-7,761 Reduced 62.75%	4,608 $173,000
Q1 2020 Jul 12, 2023	SELL	$23.08 - $35.53 $179,123 - $275,748	-7,761 Reduced 62.75%	4,608 $137,000
Q1 2020 Mar 22, 2023	SELL	$23.08 - $35.53 $179,123 - $275,748	-7,761 Reduced 62.75%	4,608 $137,000
Q1 2020 May 15, 2020	BUY	$23.08 - $35.53 $106,352 - $163,722	4,608 New	4,608 $137,000

Others Institutions Holding CSTL

# of Institutions

201

Shares Held

24.5M

Call Options Held

303K

Put Options Held

30.3K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $724M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Castle Biosciences Inc Transaction History